AAP
MED icon

Ardsley Advisory Partners’s Medifast MED Stock Holding History

Ardsley Advisory Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-95,000
Closed -$9.84M – 174
2019
Q3 		$9.84M Sell
95,000
-5,000
-5% -$537K 2.21% 16
2019
Q2 		$12.8M Buy
100,000
+20,000
+25% +$2.78M 2.02% 17
2019
Q1 		$10.2M Buy
+80,000
New +$10.1M 1.96% 20

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ardsley Advisory Partners's MED Position: Q4 2019 in Review

Ardsley Advisory Partners sold out of Medifast (MED) in Q4 2019, closing a stake of 95,000 shares — an estimated $9.84M sold.

Ardsley Advisory Partners first reported a position in MED in Q1 2019 and held it in 3 quarters. The position peaked at $12.8M in Q2 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Ardsley Advisory Partners reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Ardsley Advisory Partners sold 95,000 Medifast shares in Q4 2019, an estimated $9.84M.
  • Ardsley Advisory Partners first reported a position in Medifast in Q1 2019 and held it in 3 quarters.
  • Ardsley Advisory Partners's Medifast position peaked at $12.8M in Q2 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.